Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

Fig. 1

Associations between ARB vs. ACE-I use and delayed recall performance over time in participants with AD. Left: plot showing full range of outcome scores; Right: plot with reduced y-axis cut-off, to better show differences between ARB and ACE-I groups. Thick lines represent the total estimated association adjusted for covariates; thin lines represent estimated associations adjusted for covariates for each participant

Back to article page